Sbir niaid topic 084: "antiviral drugs to cure chronic hepatitis B virus infection"
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93020C00045
- Awardee
-
Hbvtech, L.l.c UEI WEXNYHY4EZB5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,868
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Solicitation · PHS20201 · Posted Jun 21, 2019
- Contract value 100% obligated
- $299,868.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$6,500 | |
| Change Order | $6,500 | |
| Original award | $299,868 |
About this award
This SBIR Phase I contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases, valued at $299,868, was awarded to Hbvtech of Germantown, Maryland. The contract supports research outlined in Topic 084 of the solicitation, which sought proposals for antiviral drugs to cure chronic hepatitis B virus infection. The firm-fixed price contract is a total small business set-aside running from August 2020 through October 2021. The award advances the NIH/NIAID's mission to conduct and support research on infectious diseases including hepatitis B, which remains a significant public health issue despite available vaccines and treatments.
Quick answers
Who was awarded contract 75N93020C00045?
75N93020C00045 was awarded to Hbvtech, L.l.c by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 19, 2020.
How much is contract 75N93020C00045 worth?
The government has obligated $299,868 on 75N93020C00045.
Was contract 75N93020C00045 competed?
The extent of competition for 75N93020C00045 was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award